Literature DB >> 421995

Effects of spontaneous portal-systemic shunting on insulin metabolism.

G Smith-Laing, S Sherlock, O K Faber.   

Abstract

Insulin degradation was measured by the C-peptide/insulin ratio in 19 patients with portal vein block with extensive spontaneous portal-systemic shunting but minimal liver cell damage: 13 patients with biopsy-proved cirrhosis and 12 controls. Blood obtained fasting and for 3 hr after oral glucose was assayed for glucose, insulin, and C-peptide. Fasting C-peptide and insulin levels in patients with portal vein block and those in controls did not differ. Eight of 13 cirrhotic patients had fasting hyperinsulinemia with a significantly reduced C-peptide/insulin ratio. After glucose administration, the C-peptide/insulin ratio in portal vein block patients with normal aspartate transaminase levels did not differ from control values. In portal vein block patients with elevated asparatate transaminase levels, the C-peptide/insulin ratio was significantly reduced only from 60 min onwards. All the cirrhotic patients showed a significantly reduced C-peptide/insulin ratio after glucose administration. It is suggested that portal-systemic shunting of blood in the presence of a normal liver does not influence hepatic insulin metabolism and that the hyperinsulinemia of cirrhosis is a feature of parenchymal liver damage. In addition, insulin degradation was abnormal in all cirrhotic patients at high insulin secretion rates, even when fasting insulin levels were normal.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 421995

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

1.  Endocrine aspects of liver disease.

Authors:  R G Long
Journal:  Br Med J       Date:  1980-01-26

2.  Mechanisms of hyperinsulinaemia in Child's disease grade B liver cirrhosis investigated in free living conditions.

Authors:  A V Greco; G Mingrone; A Mari; E Capristo; M Manco; G Gasbarrini
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

3.  Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3.

Authors:  Takumi Kawaguchi; Takafumi Yoshida; Masaru Harada; Takao Hisamoto; Yumiko Nagao; Tatsuya Ide; Eitaro Taniguchi; Hiroto Kumemura; Shinichiro Hanada; Michiko Maeyama; Shinji Baba; Hironori Koga; Ryukichi Kumashiro; Takato Ueno; Hisanobu Ogata; Akihiko Yoshimura; Michio Sata
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

4.  Correction of altered plasma amino acid pattern in cirrhosis of the liver by somatostatin.

Authors:  B Limberg; B Kommerell
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

5.  Insulin resistance is the main determinant of impaired glucose tolerance in patients with liver cirrhosis.

Authors:  G Marchesini; G P Bianchi; G Forlani; A G Rusticali; D Patrono; M Capelli; M Zoli; P Vannini; E Pisi
Journal:  Dig Dis Sci       Date:  1987-10       Impact factor: 3.199

6.  Augmentation effect of postprandial hyperinsulinaemia on growth of human hepatocellular carcinoma.

Authors:  K Saito; S Inoue; T Saito; S Kiso; N Ito; S Tamura; H Watanabe; H Takeda; H Misawa; H Togashi; Y Matsuzawa; S Kawata
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

7.  Metabolic handling of orally administered glucose in cirrhosis.

Authors:  Y T Kruszynska; A Meyer-Alber; F Darakhshan; P D Home; N McIntyre
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

8.  Changes in immunoreactive insulin, C-peptide immunoreactivity, and immunoreactive glucagon in acute viral hepatitis.

Authors:  K Kaneko; M Arai; H Funatomi; Y Hatta; K Mitamura
Journal:  J Gastroenterol       Date:  1995-10       Impact factor: 7.527

9.  Effects of intra- and extrahepatic portal systemic shunts on insulin metabolism.

Authors:  K Ohnishi; A Mishima; M Takashi; S Tsuchiya; S Iida; S Iwama; N Goto; K Kono; Y Nakajima; N Suzuki; H Musha; K Okuda
Journal:  Dig Dis Sci       Date:  1983-03       Impact factor: 3.199

10.  Plasma amino-acid patterns in liver disease.

Authors:  M Y Morgan; A W Marshall; J P Milsom; S Sherlock
Journal:  Gut       Date:  1982-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.